SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

National Peroxide - Quaterly Results

06 May 2025 Evaluate
The sales slipped to Rs. 737.04 millions for the March 2025 quarter as against Rs. 880.32 millions during the year-ago period.The Net Loss for the quarter ended March 2025 is Rs. -64.90 millions as compared to Net Profit of Rs. 30.72 millions of corresponding quarter ended March 2024Operating profit Margin for the quarter ended March 2025 slipped to -23.50% as compared to 94.58% of corresponding quarter ended March 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 737.04 880.32 -16.28 2868.74 3329.86 -13.85 2868.74 3329.86 -13.85
Other Income 0.03 4.32 -99.31 44.87 51.63 -13.09 44.87 51.63 -13.09
PBIDT -23.50 94.58 -124.85 196.96 427.56 -53.93 196.96 427.56 -53.93
Interest 3.85 4.73 -18.60 16.65 19.82 -15.99 16.65 19.82 -15.99
PBDT -27.35 89.85 -130.44 180.31 407.74 -55.78 180.31 407.74 -55.78
Depreciation 50.81 48.58 4.59 201.08 192.60 4.40 201.08 192.60 4.40
PBT -78.16 41.27 -289.39 -20.77 215.14 -109.65 -20.77 215.14 -109.65
TAX -13.26 10.55 -225.69 1.69 47.23 -96.42 1.69 47.23 -96.42
Deferred Tax -9.10 4.85 -287.63 -3.77 18.93 -119.92 -3.77 18.93 -119.92
PAT -64.90 30.72 -311.26 -22.46 167.91 -113.38 -22.46 167.91 -113.38
Equity 57.47 57.47 0.00 57.47 57.47 0.00 57.47 57.47 0.00
PBIDTM(%) -3.19 10.74 -129.68 6.87 12.84 -46.53 6.87 12.84 -46.53

National Peroxide Share Price

547.60 91.25 (20.00%)
04-May-2026 11:49 View Price Chart
Peers
Company Name CMP
BASF India 3720.55
Tata Chemicals 816.35
SRF 2560.60
Pidilite Inds. 1385.65
Deepak Nitrite 1736.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×